A family business: Pradaxa success lifts Boehringer
April 25, 2012Research and Development, Sales and Marketing Boehringer Ingelheim
Rapid uptake of anti-clotting drug Pradaxa in the US has helped Boehringer Ingelheim enjoy a strong year, and looks set to …
GMC won’t relax off-label prescribing guidelines
April 25, 2012Sales and Marketing GMC, Lucentis, Novartis, Roche, avastin, off label, off-label
The GMC has decided not to relax guidelines on off-label prescribing when a licensed alternative exists. The GMC’s current rules …
Paul Mannu joins Insight Research Group as consultant
April 25, 2012Business Services, Medical Communications, Sales and Marketing Cello, Insight Research Group
Paul Mannu has joined the senior research team at Insight Research Group as a consultant. For the last few years Paul …
Merck KGaA swings axe over Serono operations
April 25, 2012Manufacturing and Production, Research and Development, Sales and Marketing Cladribine, MS, Merck KGaA, Switzerland, job cuts
Merck KGaA will cut around 500 jobs from its pharmaceutical unit in Switzerland, the firm has announced. The company said …
New data shows Herceptin’s ability to increase survival
April 24, 2012Research and Development, Sales and Marketing Cancer, Cochrane, Herceptin, Roche, breast
A new review of Roche’s breast cancer drug Herceptin has confirmed its ability to increase overall survival, but concerns remain …
Shire’s Vpriv website in breach of ABPI Code
April 24, 2012Medical Communications, Sales and Marketing ABPI, Genzyme, PMCPA, Shire, Vpriv, code
Shire’s website for its Gaucher’s disease drug Vpriv has fallen foul of the ABPI’s Code of Conduct. The complaint was …
Novartis to invest $550m in new Swiss plant
April 24, 2012Manufacturing and Production GSK, Novartis, manufacturing and production
Novartis has unveiled plans to build a new manufacturing facility at its site in Stein, Switzerland, just weeks after calling …
7 steps to better talent acquisition
April 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, Talent acquisition, careers, executives
When companies complain that they can’t find enough good people, the cause, in our view, is most likely to be …
Charity challenges government on Avastin for wet AMD
April 24, 2012Sales and Marketing Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD
A leading patient group has called on the government to get to grips with the issue of off-label prescribing, as …
Quintiles appoints Tom Pike as new chief executive
April 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Quintiles, Tom Pike, biopharmaceutical
Quintiles, the biopharmaceutical services company, has appointed Tom Pike as its new chief executive, effective from 30 April. The appointment …
GSK to bring pharma plant in Sri Lanka online
April 24, 2012Manufacturing and Production BMS, GSK. Sri-Lanka, manufacturing and production
GlaxoSmithKline is due to open a newly-built manufacturing facility in Sri Lanka this week that is said to be the …
Government to speed up access to new cancer drugs
April 24, 2012Sales and Marketing CDF, Cancer, Roche, UK, avastin, government, sha
Access to England’s Cancer Drugs Fund will be speeded up, ministers have confirmed. Currently, it can take a number of …
Mylan earmarks €380m for Irish expansion
April 24, 2012Manufacturing and Production Galway, Ireland, Mylan, manufacturing and production
Generic drugmaker Mylan has announced a plan to invest €380 million in its operations in the Republic of Ireland, including …
Baxter planning $1 billion plasma facility for Atlanta
April 24, 2012Manufacturing and Production Atlanta, baxter, manufacturing, production
Baxter International has unveiled plans to build a major new manufacturing complex for its plasma-based therapies in Atlanta in the …
Falsified Medicines Directive in the EU
April 23, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Dated 16 April 2012, the European Commission has issued the Draft Template for the Written Confirmation for Active Substances Imported …
GMC to create guidance on doctors’ use of social media
April 23, 2012Medical Communications BMA, Facebook, GMC, Twitter, social media
The General Medical Council is creating new draft guidance about what it expects from doctors when they are using social …
Abbott launches online tool for ankylosing spondylitis
April 23, 2012Medical Communications AS, Abbott, NHS, NICE, ankylosing spondylitis
Abbott has launched a new online assessment tool that has the potential to change the landscape of ankylosing spondylitis (AS) …
Pfizer sells nutrition business to Nestlé for $11.9 billion
April 23, 2012Business Services, Sales and Marketing Business, Lipitor, Pfizer, nestle, nutrition
Pfizer has sold its nutrition business to Nestlé for $11.85 billion in cash. Pfizer Nutrition is a leading global pediatric …
AstraZeneca diabetes drug recommended in Europe
April 23, 2012Sales and Marketing AstraZeneca, CHMP, FDA, Merck, WHO, diabetes
AstraZeneca and Bristol-Myers Squibb’s new type II diabetes treatment Forxiga has received a positive opinion by European regulators. The European …
AstraZeneca to buy Ardea for $1.3 billion
April 23, 2012Research and Development, Sales and Marketing Ardea, AstraZeneca, febuxostat, gout
AstraZeneca is to buy Ardea Biosciences for $1 billion to help bolster its pipeline. Under the terms of the agreement, …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
